Skip to Main Content
Prescriber's Letter
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • Natural Medicines
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • COVID-19 Resources
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
    • Journal Club
  • New Drugs
    • New Drugs
    • First Time Generics
  • Help
    • User Support
    • Contact Us
  • GO TO CE/CME & Training

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

  1. Home
  2. Browse
  3. Renal & Urology
  4. Drug Use in Renal Insufficiency
  5. Endocrinology

Endocrinology

  • Benign Prostatic Hypertrophy (15)
  • Drug-Induced Nephrotoxicity (103)
  • Drug Use in Renal Insufficiency (207)
    • Bone/Joint and Rheumatology (18)
    • Cardiology (83)
    • Endocrinology (42)
    • Gastroenterology (21)
    • Hematology/Oncology (14)
    • Infectious Diseases (47)
    • Men's Health (1)
    • Neurology/Psychiatry (14)
    • Women's Health (3)
  • Hyperkalemia (11)
  • Hypernatremia (2)
  • Hyponatremia (6)
  • Incontinence (4)
  • Kidney Cancer (1)
  • Kidney Disease (27)
  • Kidney Stones (13)
  • Nephrology (52)
  • Overactive Bladder (22)
  • Resources (58)
  • Urinary Retention (6)
  • UTIs (62)
  • Urine Drug Testing (10)
31 - 42 of 42 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Article: Farxiga (far-SEE-guh) for type 2 diabetes will soon hit shelves March 2014
Article: Sliding scale insulin is still giving patients a ride on the blood glucose roller coaster January 2014
Article: Experts will debate whether gliptins (Onglyza, etc) increase cardiovascular risk in patients with type 2 diabetes November 2013
PL Voices: Gliptins and Cardiovascular Risk November 2013
Article: Nesina (nes-SEE-na, alogliptin) will compete for your prescription in a crowded market of gliptins for type 2 diabetes August 2013
Commentary: New Drug: Invokana (Canagliflozin) May 2013
Article: Invokana (in-vo-KAHN-uh, canagliflozin), the first in a new class of oral drugs for type 2 diabetes May 2013
PL Voices: Managing Type 2 Diabetes in Elderly Patients November 2012
Article: Treating diabetes in the elderly brings up challenges November 2012
Article: new option for adjusting medications in adults with kidney disease October 2009
Article: metformin is no longer contraindicated in patients with heart failure February 2008
Guideline: Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach (2012) November 2006
  • « Prev
  • 1
  • 2
  • 3
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved